For example, only the combined use of focal radiation therapy and CTLA-4 inhibition therapy did induce activation of systemic anti-tumor T-cells in metastatic NSCLC, whereas the latter therapy alone was largely ineffective [62]. This evidence concerns the gene CTLA4 and neoplasm.